Anna Patrikidou

3.6k total citations · 1 hit paper
82 papers, 2.2k citations indexed

About

Anna Patrikidou is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Anna Patrikidou has authored 82 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 36 papers in Pulmonary and Respiratory Medicine and 19 papers in Surgery. Recurrent topics in Anna Patrikidou's work include Prostate Cancer Treatment and Research (20 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Cancer, Lipids, and Metabolism (9 papers). Anna Patrikidou is often cited by papers focused on Prostate Cancer Treatment and Research (20 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Cancer, Lipids, and Metabolism (9 papers). Anna Patrikidou collaborates with scholars based in France, Greece and United Kingdom. Anna Patrikidou's co-authors include Christos N. Papandreou, Karim Fizazi, Eleana Hatzidaki, Yohann Loriot, Laurence Albigès, Christophe Massard, Konstantinos Vahtsevanos, Αthanassios Kyrgidis, Panagiotis J. Vlachostergios and E. Ileana and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Anna Patrikidou

78 papers receiving 2.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

European Association of Urology Guidelines on Testicular Cancer: 2023 Update

2023 99 citations Anna Patrikidou et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Patrikidou France	23	924	761	412	366	359	82	2.2k
Aina He China	32	749 0.8×	891 1.2×	412 1.0×	405 1.1×	900 2.5×	83	2.8k
Sérgio Serrano Spain	26	615 0.7×	1.0k 1.4×	364 0.9×	354 1.0×	694 1.9×	90	2.2k
Hye Sook Min South Korea	30	830 0.9×	814 1.1×	786 1.9×	253 0.7×	533 1.5×	114	2.9k
Irene Sulzbacher Austria	27	564 0.6×	422 0.6×	486 1.2×	204 0.6×	514 1.4×	66	2.0k
Abraham Schneider United States	28	399 0.4×	1.4k 1.9×	303 0.7×	294 0.8×	1.1k 2.9×	73	3.3k
Torsten Hansen Germany	30	536 0.6×	976 1.3×	995 2.4×	136 0.4×	281 0.8×	113	2.9k
Feng Lin China	27	600 0.6×	647 0.9×	234 0.6×	318 0.9×	605 1.7×	75	2.0k
Ferdinand Ploner Austria	14	365 0.4×	631 0.8×	149 0.4×	195 0.5×	283 0.8×	27	1.3k
Sang Yoon Kim South Korea	30	537 0.6×	512 0.7×	717 1.7×	115 0.3×	232 0.6×	98	2.5k
Tim Van den Wyngaert Belgium	24	484 0.5×	1.0k 1.4×	463 1.1×	109 0.3×	188 0.5×	98	2.3k

Countries citing papers authored by Anna Patrikidou

Since Specialization

Citations

This map shows the geographic impact of Anna Patrikidou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Patrikidou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Patrikidou more than expected).

Fields of papers citing papers by Anna Patrikidou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Patrikidou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Patrikidou. The network helps show where Anna Patrikidou may publish in the future.

Co-authorship network of co-authors of Anna Patrikidou

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Patrikidou. A scholar is included among the top collaborators of Anna Patrikidou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Patrikidou. Anna Patrikidou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gonnet, Philippe, Eliana Marinari, Vérane Achard, et al.. (2024). Brain Metastases from Genito-Urinary Cancers in the Canton of Geneva (Switzerland): Study of Incidence, Management and Outcomes. Cancers. 16(20). 3437–3437.

Saieva, Calogero, Richard M. Lee‐Ying, Pier Vitale Nuzzo, et al.. (2023). Efficacy and safety of docetaxel (D) vs androgen-receptor signaling inhibitors (ARSi) as second-line therapy (Rx) after progression on alternative ARSi as first-line Rx for patients who are elderly (≥75 years old) with metastatic castration-resistant prostate cancer (mCRPC) in a multicenter international database: A SPARTACUSS–Meet-URO 26 study.. Journal of Clinical Oncology. 41(6_suppl). 166–166. 1 indexed citations

Auclin, Édouard, Anna Patrikidou, Laura Mezquita, et al.. (2023). Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma. Cancers. 15(4). 1066–1066. 10 indexed citations

Flippot, Ronan, Anna Patrikidou, Mihaela Aldea, et al.. (2022). PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer. Drugs. 82(7). 719–733. 15 indexed citations

Koloutsos, Georgios, et al.. (2021). Prevention of Frey’s Syndrome with the Use of Porcine Dermal Collagen Graft: Retrospective Analysis of 76 “Formal” Parotidectomies for Benign Pathologies. Annals of Otology Rhinology & Laryngology. 130(9). 1036–1043. 1 indexed citations

Patrikidou, Anna, et al.. (2021). Should androgen deprivation therapy and other systemic treatments be used in men with prostate cancer and a rising PSA post-local treatments?. Therapeutic Advances in Medical Oncology. 13. 4277463902–4277463902. 5 indexed citations

Olivier, Timothée, Eugenio Fernández, Sana Intidhar Labidi‐Galy, et al.. (2021). Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm?. Cancer Treatment Reviews. 97. 102204–102204. 26 indexed citations

Formica, Vincenzo, Cristina Morelli, Anna Patrikidou, et al.. (2020). Gastric Inflammatory Prognostic Index (GIPI) in Patients with Metastatic Gastro-Esophageal Junction/Gastric Cancer Treated with PD-1/PD-L1 Immune Checkpoint Inhibitors. Targeted Oncology. 15(3). 327–336. 17 indexed citations

Patrikidou, Anna, Pierre Maroun, Jean‐Jacques Patard, et al.. (2018). Helping patients make informed decisions. Two-year evaluation of the Gustave Roussy prostate cancer multidisciplinary clinic. Clinical and Translational Radiation Oncology. 12. 28–33. 6 indexed citations

10.

Schernberg, Antoine, F. Dhermain, Samy Ammari, et al.. (2017). Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients. Cancer/Radiothérapie. 22(1). 9–16. 15 indexed citations

11.

Patrikidou, Anna, et al.. (2017). Head and neck Merkel cell carcinoma: a retrospective case series and critical literature review with emphasis on treatment and prognosis. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 125(2). 126–139. 4 indexed citations

12.

Blanchard, Pierre, Stéphane Temam, C. El Khoury, et al.. (2016). Outcomes and prognostic factors for squamous cell carcinoma of the oral tongue in young adults: a single-institution case-matched analysis. European Archives of Oto-Rhino-Laryngology. 274(3). 1683–1690. 45 indexed citations

13.

Patrikidou, Anna, Julien Dômont, Sylvie Chabaud, et al.. (2015). Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group. European Journal of Cancer. 52. 173–180. 63 indexed citations

14.

Patrikidou, Anna, et al.. (2015). Introducing Cytology-Based Theranostics in Oral Squamous Cell Carcinoma: A Pilot Program. Pathology & Oncology Research. 22(2). 401–411. 2 indexed citations

15.

Loriot, Yohann, Diletta Bianchini, E. Ileana, et al.. (2013). Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100). Annals of Oncology. 24(7). 1807–1812. 273 indexed citations

16.

Patrikidou, Anna, Panagiotis J. Vlachostergios, Ioannis A. Voutsadakis, et al.. (2011). Inverse baseline expression pattern of the NEP/neuropeptides and NFκB/proteasome pathways in androgen-dependent and androgen-independent prostate cancer cells. Cancer Cell International. 11(1). 13–13. 17 indexed citations

17.

Kyrgidis, Αthanassios, Thrasyvoulos Tzellos, Anna Patrikidou, et al.. (2010). Cutaneous squamous cell carcinoma (SCC) of the head and neck: Risk factors of overall and recurrence-free survival. European Journal of Cancer. 46(9). 1563–1572. 93 indexed citations

18.

Patrikidou, Anna, et al.. (2009). Adnexal Skin Carcinomas of the Face. Journal of Craniofacial Surgery. 20(1). 134–137. 1 indexed citations

19.

Vlachostergios, Panagiotis J., Anna Patrikidou, Danai Daliani, & Christos N. Papandreou. (2009). The ubiquitin‐proteasome system in cancer, a major player in DNA repair. Part 2: transcriptional regulation. Journal of Cellular and Molecular Medicine. 13(9b). 3019–3031. 15 indexed citations

20.

Baqain, Zaid H., et al.. (2004). Antibiotic prophylaxis for orthognathic surgery: a prospective, randomised clinical trial. British Journal of Oral and Maxillofacial Surgery. 42(6). 506–510. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact